Cousineau I - Search Results

1

Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.

Demeule M, Currie JC, Charfi C, Zgheib A, Cousineau I, Lullier V, Béliveau R, Marsolais C, Annabi B. Demeule M, et al. Among authors: cousineau i. Front Immunol. 2024 Feb 28;15:1389603. doi: 10.3389/fimmu.2024.1389603. eCollection 2024. Front Immunol. 2024. PMID: 38482002 Free PMC article.

2

Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing.

Demeule M, Currie JC, Charfi C, Zgheib A, Cousineau I, Lullier V, Béliveau R, Marsolais C, Annabi B. Demeule M, et al. Among authors: cousineau i. Front Immunol. 2024 Feb 16;15:1355945. doi: 10.3389/fimmu.2024.1355945. eCollection 2024. Front Immunol. 2024. PMID: 38482021 Free PMC article.

3

CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.

Jacoberger-Foissac C, Cousineau I, Bareche Y, Allard D, Chrobak P, Allard B, Pommey S, Messaoudi N, McNicoll Y, Soucy G, Koseoglu S, Masia R, Lake AC, Seo H, Eeles CB, Rohatgi N, Robson SC, Turcotte S, Haibe-Kains B, Stagg J. Jacoberger-Foissac C, et al. Among authors: cousineau i. Cancer Immunol Res. 2023 Jan 3;11(1):56-71. doi: 10.1158/2326-6066.CIR-22-0260. Cancer Immunol Res. 2023. PMID: 36409930 Free PMC article.

4

The CD73 immune checkpoint promotes tumor cell metabolic fitness.

Allard D, Cousineau I, Ma EH, Allard B, Bareche Y, Fleury H, Stagg J. Allard D, et al. Among authors: cousineau i. Elife. 2023 Jun 1;12:e84508. doi: 10.7554/eLife.84508. Elife. 2023. PMID: 37261423 Free PMC article.

5

EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.

Cousineau I, Belmaaza A. Cousineau I, et al. Mol Genet Genomics. 2011 Apr;285(4):325-40. doi: 10.1007/s00438-011-0612-5. Epub 2011 Mar 16. Mol Genet Genomics. 2011. PMID: 21409565 Free PMC article.

6

Adenosine A2a receptor promotes lymphangiogenesis and lymph node metastasis.

Allard B, Cousineau I, Allard D, Buisseret L, Pommey S, Chrobak P, Stagg J. Allard B, et al. Among authors: cousineau i. Oncoimmunology. 2019 Apr 26;8(8):1601481. doi: 10.1080/2162402X.2019.1601481. eCollection 2019. Oncoimmunology. 2019. PMID: 31413909 Free PMC article.

7

Optimal CCN4 Immunofluorescence for Tissue Microarray.

Gaudreau PO, Cousineau I, Stagg J. Gaudreau PO, et al. Among authors: cousineau i. Methods Mol Biol. 2023;2582:13-21. doi: 10.1007/978-1-0716-2744-0_2. Methods Mol Biol. 2023. PMID: 36370340

8

Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assays.

Allard B, Cousineau I, Spring K, Stagg J. Allard B, et al. Among authors: cousineau i. Methods Enzymol. 2019;629:269-289. doi: 10.1016/bs.mie.2019.10.007. Epub 2019 Oct 25. Methods Enzymol. 2019. PMID: 31727245

9

Disruption of p53 by the viral oncoprotein HPV16-E6 does not deregulate chromosomal homologous recombination in a transcriptional interference-free assay system.

Lemelin JF, Abaji C, Cousineau I, Belmaaza A. Lemelin JF, et al. Among authors: cousineau i. Cell Cycle. 2005 Jun;4(6):831-7. doi: 10.4161/cc.4.6.1725. Epub 2005 Jun 8. Cell Cycle. 2005. PMID: 15908792

10

Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma.

Allard B, Jacoberger-Foissac C, Cousineau I, Bareche Y, Buisseret L, Chrobak P, Allard D, Pommey S, Ah-Pine F, Duquenne S, Picard F, Stagg J. Allard B, et al. Among authors: cousineau i. Cell Rep Med. 2023 Sep 19;4(9):101188. doi: 10.1016/j.xcrm.2023.101188. Cell Rep Med. 2023. PMID: 37729873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page